Reality Television Programs Are Associated With Illegal Drug Use and Prescription Drug Misuse Among College Students

2015 ◽  
Vol 51 (1) ◽  
pp. 62-72 ◽  
Author(s):  
Joshua Fogel ◽  
Alexander Shlivko
Author(s):  
Dennis C. Daley ◽  
Antoine Douaihy

A substance problem is any negative outcome from prescription drug misuse, illegal drug use, or binge drinking. These problems often lead to substance use disorders (SUDs). Any substance use can cause problems. The real issues are a person’s reasons for using, and whether that substance use is part of a substance use disorder. Family members often think of the drug as being the problem when it is really the person’s pattern of use and reasons for using that are the problems. Drugs come and go and are replaced by new ones all the time. SUDs and addiction are people problems that involve drugs.


2020 ◽  
Vol 3 ◽  
pp. 1-12
Author(s):  
Kelly Gagnon ◽  
Jessica Frankeberger ◽  
Stephanie Corey ◽  
Barbara L. Folb ◽  
Christina Mair ◽  
...  

  Background: The United States Institute of Medicine (IOM) published reports in 1999 and 2011 identifying drug use as a priority area for sexual minority health research, specifically focused on mechanisms contributing to drug use disparities and the development of tailored interventions. Limited research has prioritized sexual minority women (SMW) with the majority of substance use research among sexual minorities focused on adolescents and men who have sex with men. This scoping review will characterize the research literature related to illicit drug use and prescription drug misuse among SMW and sub-groups within the SMW population. Through this, we will identify: (1) specific substances used; (2) patterns of substance use; (3) risk and protective factors; (4) prevention interventions; and (5) drug treatment programs specific to SMW. Methods/Design: This review will include studies with empirical data of illicit or prescription drug misuse among sexual minority women. Peer-reviewed quantitative research conducted in the United States and published in English from 2011-Present will be included. We will search Medline, PsycINFO, and Web of Science databases for relevant articles. Two independent reviewers will screen abstracts and relevant full-text studies for eligibility. Data will be extracted from eligible articles and results will be presented in narrative and tabular form as appropriate. Discussion: This work will identify gaps of knowledge in the research pertaining to illicit or prescription drug misuse among sexual minority women since the 2011 US IOM report. As a result of this work, we will propose directions for future research to address identified gaps.


2020 ◽  
Vol 50 (4) ◽  
pp. 566-578
Author(s):  
Yen-Han Lee ◽  
Yen-Chang Chang ◽  
Ching-Ti Liu ◽  
Stephan Arndt

This research focuses on associations of medical marijuana legalization with prescription drug misuse, illicit drug use, and a combination of both behaviors. Using three waves of the National Survey of Drug Use and Health (NSDUH, 2016–2018), adult participants (age ≥ 18) were selected for the final study sample ( n = 127,438). Multinomial logistic regression was adjusted for biological, socioeconomic, and substance use measurements. Results from multinomial regression demonstrated that medical marijuana legalization was positively associated with illicit drug use (relative risk ratio [RRR] = 1.33, 95% confidence interval [CI] = [1.17, 1.51]; p < .01) and both prescription drug misuse and illicit drug use (RRR = 1.14, 95% CI = [1.05, 1.25]; p < .01) among U.S. adults. It is recommended to design policy interventions to counter illicit drug use and a combination of both prescription drug misuse and illicit drug use as the result of medical marijuana legalization.


2020 ◽  
Vol 136 (1) ◽  
pp. 47-51
Author(s):  
Benjamin H. Han ◽  
Elizabeth Mello ◽  
Ellenie Tuazon ◽  
Denise Paone

Objectives Estimating the prevalence of drug use in the general population is important given its potential health consequences but is challenging. Self-reported surveys on drug use have inherent limitations that underestimate drug use. We evaluated the performance of linking urine drug testing with a local, representative health examination survey in estimating the prevalence of drug use in New York City (NYC). Methods We used urine drug testing from the NYC Health and Nutrition Examination Survey (NYC HANES) to estimate the prevalence of drug use (benzodiazepines, cocaine, heroin, and opioid analgesics) among the study sample and compare the findings with self-reported responses to questions about past–12-month drug use from the same survey. Results Of 1527 respondents to NYC HANES, urine drug testing was performed on 1297 (84.9%) participants who provided urine and consented to future studies. Self-reported responses gave past–12-month weighted estimates for heroin, cocaine, or any prescription drug misuse of 13.8% (95% CI, 11.6%-16.3%), for prescription drug misuse of 9.9% (95% CI, 8.1%-12.1%), and for heroin or cocaine use of 6.1% (95% CI, 4.7%-7.9%). Urine drug testing gave past–12-month weighted estimates for any drug use of 4.3% (95% CI, 3.0%-6.0%), for use of any prescription drug of 2.8% (95% CI, 1.9%-4.1%), and for heroin or cocaine use of 2.0% (95% CI, 1.2%-3.6%). Conclusion Urine drug testing provided underestimates for the prevalence of drug use at a population level compared with self-report. Researchers should use other methods to estimate the prevalence of drug use on a population level.


2018 ◽  
Vol 21 ◽  
pp. S190
Author(s):  
C Iloabuchi ◽  
Z Xiaohui ◽  
E Aboaziza ◽  
JD Thornton ◽  
N Dwibedi

Sign in / Sign up

Export Citation Format

Share Document